Bridging the Last Mile of Acute Cardiology: Synthesized 3D Vectorcardiography at Home
Dr. Dereck Mush, MD, MBA
HeartFlow
Non-invasive precision coronary care using computer-aided analysis of coronary arteries.
What they do
The company utilizes deep learning and computed tomography data to construct personalized 3D models of patients' coronary arteries. This allows clinicians to analyze blood flow restriction and diagnose coronary artery disease without invasive procedures.
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Cardiovascular diagnostics
- Product type
- Software as a medical device
- Stage
- Series C+
- Headquarters
- Mountain View, USA
- Region
- North America
- Founded
- 2007
- Total funding
- $640M raised
Notable investors: Baillie Gifford, Fidelity, Sands Capital, BlueCross BlueShield Venture Partners.
Also in Imaging & Diagnostics
Related on The Signal
Dr. Dereck Mush, MD, MBA
Top 25 Cardiologists to Follow on LinkedIn in 2026
Dr. Dereck Mush, MD, MBA
The Coronary Plaque Reimbursement Playbook: Inside Elucid's $55M Raise and the Economics of Non-Invasive Cardiovascular AI
Dr. Dereck Mush, MD, MBA
Menopause benefits are expanding past hot flashes into cardiovascular and bone health
Dr. Dereck Mush, MD, MBA